Quantcast

Latest Islet cell transplantation Stories

2008-07-30 09:01:27

WASHINGTON, July 30 /PRNewswire-FirstCall/ -- The ability of blood tests to precisely measure very low doses of anti-rejection drugs in kidney transplant patients may make a significant difference in assuring long-term viability and survival, according to research presented today at the American Association for Clinical Chemistry (AACC) annual meeting. The current thinking in transplant medicine favors reducing doses of tacrolimus and other immune-suppressive drugs as much as possible...

c7dd721bb61e51f63f7da5c13b496ab01
2008-04-09 10:24:42

One day it may be possible to mimic the tactics used by parasites to trick the body into accepting transplanted tissues or organs.That is the hope of Dr Shane Grey from the Garvan Institute for Medical Research and Professor John Dalton from the Institute for the Biotechnology of Infectious Diseases at the University of Technology (UTS). The pair has been awarded a $400,000 grant through the Australian Islet Transplantation Program, administered jointly by the Juvenile Diabetes Research...

2008-01-28 16:55:00

Demi-Lee Brennan, a 15-year-old Australian transplant recipient has become the first person in the world to change blood groups and assume the immune system of her donor. "It's like my second chance at life," said Brennan.  "It's kind of hard to believe," she added, speaking of how her body achieved what doctors called a "one-in-six-billion miracle."Brennan received her liver transplant six years ago at age 9 after her own liver had failed.  She changed blood group from O negative...

2008-01-23 06:00:54

Reportlinker.com announces that a new market research report related to the Health Care industry is available in its catalogue. Organ Transplant Immunosuppressive Markets To order that report: www.reportlinker.com/p075365/Organ-Transplant- Immunosuppressive-Markets.html (Due to its length, this URL may need to be copied/pasted into your Internet browser's address field. Remove the extra space if one exists.) For more information, contact Nicolas by email nbo@reportlinker.com ,...

2007-06-26 12:08:49

SAN DIEGO, June 26, 2007 (PRIME NEWSWIRE) -- MicroIslet, Inc. (OTCBB:MIIS) (the "Company") announced today that Jonathan R. T. Lakey, Ph.D., M.S.M., was named the Company's Chief Scientific Officer and elected to the Company's Board of Directors. Dr. Lakey is a co-developer of the Edmonton Protocol, an internationally recognized treatment for type 1 diabetes. Other new Board members are Keith B. Hoffman, Ph.D., Michael J. Andrews, and Ronald Katz, CPA. The new board members replace Dr....

2006-01-19 14:15:00

By David Douglas NEW YORK (Reuters Health) - In certain patients with diabetes-related kidney disease, performing a transplant before the need for dialysis arises seems to be advantageous, researchers report. "Preemptive transplantation remains an optimal form of kidney replacement therapy for individuals with diabetes when they receive a living donor kidney -- or when they receive a simultaneous pancreas-kidney transplant, in the case of individuals with type 1 diabetes," Dr. Bryan N. Becker...

2005-12-30 16:32:17

By Karla Gale NEW YORK (Reuters Health) - Researchers at Harvard Medical School have developed a protocol in mice in which insulin-producing islet cells are labeled with a magnetic imaging probe that can be detected by MRI, thus representing a potential easy noninvasive way for doctors to follow islet cell transplantation in humans. Islet cell transplantation is a promising therapy for insulin-dependent or type 1 diabetes. "Right now, all we can do to follow the fate of transplanted...

2005-11-29 13:43:44

CHICAGO - Researchers are using a new cell transplantation technique to restore the cells that produce insulin in patients with type 1 diabetes. The method is minimally invasive, with few complications. The study was presented today at the annual meeting of the Radiological Society of North America (RSNA). "We used ultrasound guidance to inject donor cells into the portal vein of diabetic patients, which is accessed through the skin," said co-author Saravanan Krishnamoorthy, M.D., radiology...

2005-06-28 15:40:30

By David Douglas NEW YORK (Reuters Health) - People with type 1 diabetes often develop kidney failure and, when it's available, a combined kidney and pancreas transplant offers the prospect of curing both problems. Now Italian researchers report that a pancreas transplant alone has a lasting beneficial effect on kidney impairment related to diabetes. Dr. Piero Marchetti of the University of Pisa and colleagues note that pancreas transplantation greatly helps people with diabetes by...

2005-06-13 16:26:21

Approximately 600 children receive liver transplants each year in the United States. The use of immunosuppressant drug therapy, namely calcineurin inhibitors (CNIs) such as cyclosporine and tacrolimus, has decreased the risk of liver rejection and increased patient survival rates. While these medications can aid positive outcomes, high levels of CNIs can cause seizures and kidney damage, and low levels increase the risk of rejection of the transplanted liver. A study in the June issue of The...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related